PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Translational Immunology Laboratory, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.\', \'Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología (CNB-CSIC), Madrid, Spain.\', \'Intensive Care Department, Hospital Universitario Central de Asturias, Oviedo, Spain.\', \'Translational Microbiology Research Group, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.\', \'Infectious Diseases Unit, Translational Research in Infectious Diseases Group, Hospital Universitario Central de Asturias, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.\', \'Translational Immunology Laboratory, Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain. inmuno@hca.es.\', \'Department of Immunology, Hospital Universitario Central De Asturias, Oviedo, Spain. inmuno@hca.es.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13148-021-01168-5
?:doi
?:hasPublicationType
?:journal
  • Clinical epigenetics
is ?:pmid of
?:pmid
?:pmid
  • 34635175
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.435
?:rankingScore_hIndex
  • 31
is ?:relation_isRelatedTo_publication of
?:title
  • Epigenetic targeting of the ACE2 and NRP1 viral receptors limits SARS-CoV-2 infectivity.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all